What pharmabiz.com does

Pharmabiz.com is identified solely by its domain name; the supplied input material is corrupted and contains no parseable content describing the company's operations, products, customers, or business model. Based on the domain name alone, the entity is associated with the Indian pharmaceutical sector, but no factual details about its product surface, revenue mechanics, audience, or technology stack can be extracted from the input. As a result, this description is intentionally minimal: the company is recognized as a web property operating in the pharmaceutical information space, but specifics are not available in the supplied data.

Because the input does not contain source IDs, named products, customer logos, pricing model, or any other verifiable data points, the remainder of this profile is reported as unknown rather than fabricated. No claims are made that are not grounded in the supplied text.

Name

pharmabiz.com

Legal name

Saffron Media India Pvt. Ltd.

Website

https://pharmabiz.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

11–50 employees

Short description

Pharmabiz.com operates in the pharmaceutical information space, but the supplied input is corrupted and provides no verifiable details about its specific products, audience, or revenue model.

Ownership category

akta.pro rank

Product category

Pharmaceutical Industry News & Intelligence

NAICS

Periodical Publishers (513120), Directory and Mailing List Publishers (51314)

akta.pro primary industry

B2B / Industrial Market Research (MPAAALAA)

Keywords

• Pharmaceutical industry news
• Pharma business intelligence
• Regulatory drug updates
• Pharma tender listings
• Pharmaceutical newsletter

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Digital Commerce or Content

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Subscription Services: Pharmabiz generates revenue through subscription-based services including Pharmabiz Services (access to industry databases, company profiles, regulatory information, archives) and ePharmail daily electronic newsletter delivered every morning except Sundays and Indian public holidays. A combined package offer is available at a discounted rate.
2. Advertising: The platform generates revenue from display advertising, with unique advertisers numbering over 3080 from various countries including India, Bangladesh, Brasil, Canada, China, Croatia, Germany, Nepal, Pakistan, Russia, Singapore, Sri Lanka, Sudan, Syria, UK, USA and Yemen.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Pharmabiz.com is an online B2B portal that publishes pharmaceutical industry news, regulatory updates from agencies such as the US FDA, drug approvals, government tenders, patent information, and corporate data. It delivers content through its web portal, a daily email newsletter (ePharmail), and a weekly print edition (Chronicle Pharmabiz), and operates PharMart, a B2B marketplace for pharmaceutical buyers and suppliers.

Product overview

Pharmabiz.com is a comprehensive pharmaceutical industry portal owned by Saffron Media Pvt. Ltd., operating as a platform-plus-modules architecture. The core product is Pharmabiz Services, a subscription-based membership providing access to industry data. This is supplemented by ePharmail (daily email newsletter), Chronicle Pharmabiz (weekly print publication), and PharMart (B2B marketplace). Additional modules cover US FDA updates, export/import services, pharma laws & documents, company profiles, and editorial/news content. The platform serves as a one-stop destination for pharmaceutical professionals seeking news, regulatory information, tenders, project data, and business intelligence.

Differentiator

Problem solved

Functional benefit

Brands

• PharMart: Pharma marketplace platform revolutionizing pharmaceutical procurement, featuring categories including APIs, excipients, analytical instruments, cleanroom equipment, contract research, IT solutions, logistics, packaging, machinery, testing services, water treatment, finished formulations, biotechnology, and clinical research services.

Products and services

• Pharmabiz Services Subscription-based membership providing access to the pharmabiz.com portal with pharma industry news, regulatory updates, US FDA news, drug approvals, tenders, patents, pharma laws and documents, company profiles, and corporate data, targeted at pharmaceutical industry professionals in India and South Asia.
• ePharmail Daily email newsletter delivering pharmaceutical industry news, regulatory updates, and key developments to pharma professionals' inboxes.
• Chronicle Pharmabiz Weekly print edition of pharmabiz.com covering pharmaceutical industry news, regulatory developments, and market intelligence for pharma professionals.
• PharMart

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators4 records

Recent moves1 record

Expansion highlights1 record

Broad incumbents

• Pharmaceutical Executive: Established pharma trade magazine (under MJH Life Sciences) targeting pharmaceutical executives with industry analysis and regulatory coverage. Comparable as a B2B pharma publication serving C-suite readers.
• Informa Pharma Intelligence: Global pharma intelligence division of Informa plc, operating brands such as Scrip, Pink Sheet and Citeline. Comparable as a subscription-based B2B pharma intelligence provider serving regulatory, clinical and commercial decision-makers worldwide.

Regional players

• Drug Discovery & Development: B2B media outlet covering drug R&D, manufacturing and regulatory developments. Comparable as a specialized pharma trade publication with digital content and advertiser base.
• PharmaTimes: UK-based pharmaceutical trade publication covering industry news, clinical updates and policy. Comparable as a long-running pharma trade media brand with multi-format content (online and print).

Direct peers

• Express Pharma: Indian pharmaceutical trade publication; particularly comparable because P A Francis, head of Pharmabiz, was also the founder editor of Express Pharma Pulse. Both target pharma professionals in India with weekly news and analysis.
• BioSpace: Long-standing B2B media and jobs platform covering the biopharma industry. Comparable subscription and advertising monetization model serving pharma employers, job seekers and industry news consumers.
• The Pharma Letter: Subscription-based pharma industry intelligence service offering daily news and in-depth reports. Comparable subscription/newsletter-driven model targeting pharma professionals.
• Fierce Pharma: U.S.-based B2B digital media outlet covering pharma industry news, regulatory updates and business intelligence. Comparable business model and audience (pharma executives) to Pharmabiz, though broader geographic reach.

Emerging players

• Endpoints News: Digital-first news outlet covering the biopharma industry. Comparable as a subscription-supported B2B pharma media product targeting industry executives.
• Pharma Source: B2B resource hub for pharmaceutical manufacturing, CDMOs and supply chain professionals. Comparable as a niche B2B publishing platform serving pharma manufacturers, though with a more manufacturing-focused editorial lens.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat2 records

Key risks7 records

Key highlights6 records

Customer concentration

• Xtwitter.com/intent/follow?ref_src=twsrc%5Etfw%7Ctwcamp%5Ebuttonembed%7Ctwterm%5Efollow%7Ctwgr%5Epharmabiznews®ion=follow_link&screen_name=pharmabiznews
• LinkedInlinkedin.com/comm/mynetwork/discovery-see-all?usecase=PEOPLE_FOLLOWS&followMember=chroniclepharmabiz
• Instagraminstagram.com/chroniclepharmabiz2000

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about pharmabiz.com